• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD. ATELLICA IM HBC TOTAL 2 (HBCT2); TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD. ATELLICA IM HBC TOTAL 2 (HBCT2); TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Model Number N/A
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/29/2023
Event Type  malfunction  
Event Description
The customer reports observation of nonreactive (negative) atellica im hbc total 2 (hbct2) results which were discordant relative to alternate-method testing.Hbct2 lot 008 was in use at the time.A nonreactive (negative) hbct2 result was obtained for a 28-year-old male patient with a history of a positive ahbct result 6 months earlier.This negative result was not reported to the physician.Re-testing of the same sample using the atellica im anti-hepatitis b core total (hbct) test produced a reactive (positive) result.The customer sent this patient¿s sample to another laboratory for confirmation.There are no allegations of patient harm, changes in treatment, or delays of diagnosis in association with the observed discordance.
 
Manufacturer Narrative
A customer from outside the united states reported observation of a nonreactive (negative) atellica im hbc total 2 (hbct2) results which were discordant relative to patient history and alternate-method testing.Testing was repeated for investigation purposes.Both methods (hbct2 and hbct) reproduced the initial observations: negative by hbct2, positive by hbct.The assay's instructions for use (ifu) states the following, under limitations: "the performance of the assay has not been established for populations of immunocompromised or immunosuppressed patients." "patient samples may contain heterophilic antibodies that could react in immunoassays to give falsely elevated or depressed results.This assay is designed to minimize interference from heterophilic antibodies.Additional information may be required for diagnosis." siemens is investigating.
 
Manufacturer Narrative
Mdr 1219913-2023-00283 was initially submitted on 2023-11-07.A customer from outside the united states reported observation of nonreactive (negative) atellica im hbc total 2 (hbct2) results which were discordant relative to alternate-method testing.Atellica im hbct2 results for this patient were reproducibly negative, while hbct results were reactive (positive).The patient's sample was tested at an external lab using a third method, and a negative result was returned.Based on the available information, the probable cause for the discordant results is a sample-specific assay interferent.The customer is operational, and no product problem was identified.Note: in section h6, the codes for investigation findings and investigation conclusion have been updated.Manufacturer information in section d3 has been corrected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM HBC TOTAL 2 (HBCT2)
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD.
glyn rhonwy
llanberis
caernarfon NY LL554 EL
UK  LL554EL
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
333 coney st.
east walpole MA 02032
Manufacturer Contact
barry memishian
333 coney st.
east walpole, MA 02032
5082985306
MDR Report Key18085150
MDR Text Key327770380
Report Number1219913-2023-00283
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00630414604138
UDI-Public00630414604138
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P210019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number11200739
Device Lot Number008
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/16/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age28 YR
Patient SexMale
-
-